GLIF get Grant Life Sciences Inc in front of our investor member network.Grant Life Sciences Inc Details:Grant Life Sciences, Inc., a development stage company, engages in the development of protein-based screening tests to screen women for cervical cancer and pre-cancerous conditions. The company’s tests detect the presence of various antibodies that appear when cervical cancer or pre-cancerous conditions are present in the body by analyzing a small amount of the patient’s blood. It also holds rights to diagnostic devices for HIV-1, HIV-2, and dengue fever testing; and a proprietary colloidal gold reagent, an ingredient used by manufacturers of rapid tests. The company, formerly known as Grant Ventures, Inc., was founded in 1998 and is based in Salt Lake City, Utah.HEALTH CARE SECTOR | BIOTECHNOLOGY INDUSTRY Grant Life Sciences, Inc. (GLIF:OTC)
GLIF On Other Exchanges
GLIF DetailsGrant Life Sciences, Inc., a development stage company, engages in the development of protein-based screening tests to screen women for cervical cancer and pre-cancerous conditions. The company’s tests detect the presence of various antibodies that appear when cervical cancer or pre-cancerous conditions are present in the body by analyzing a small amount of the patient’s blood. It also holds rights to diagnostic devices for HIV-1, HIV-2, and dengue fever testing; and a proprietary colloidal gold reagent, an ingredient used by manufacturers of rapid tests. The company, formerly known as Grant Ventures, Inc., was founded in 1998 and is based in Salt Lake City, Utah. Detailed Description...
www.grantlifesciences.com
Founded in 1998
Latest 10-K
Latest 10-Q
More SEC Filings...
Top Compensated Officers
Dr. Hun-Chi Lin Ph.D.
Principal Executive Officer, President, Chief...
Age: 54
Total Annual Compensation: $90.0K
Mr. Michael Ahlin MBA
Vice President and Director
Age: 58
Total Annual Compensation: $30.0K
Mr. Donald W. Rutherford
Consultant
Age: 67
Total Annual Compensation: $29.6K
Executives, Board Directors Compensation as of Fiscal Year 2007.
Key developmentsGrant Life Sciences Inc. has Changed its Ticker to GLIF.E from GLIF
08/20/2008
Effective August 20, 2008, Grant Life Sciences Inc. changed its OTCBB stock ticker symbol to GLIF.E from GLIF. Grant Life Sciences Inc. Announces Amendments to Articles of Incorporation or Bylaws
06/6/2008
On June 4, 2008, Grant Life Sciences Inc. filed a Certificate of Designation establishing the Voting Powers, Designations, Preferences, Limitations, Restrictions, and Relative Rights of Series A Convertible Preferred Stock such that the number of shares constituting the Preferred Stock shall be 4,000,000. Holders of Preferred Stock shall be entitled to vote on all matters submitted to shareholders of the Company and shall be entitled to one hundred and fifty votes for each share of Preferred Stock owned at the determined record date. Subject to the terms of the Certificate of Designation, each share of Preferred Stock is convertible into ten shares of the Company's Common Stock. Grant Life Sciences, Inc. announced delayed 10-Q filing
05/14/2008
On 05/14/2008, Grant Life Sciences, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC. 
Stock QuotesCompetitors
Industry Analysis
View Detailed Financials
|
View Sector Analysis
transactions
Recent News About Grant Life Sciences Inc
Besides Grant Life Sciences Inc there is more great information available at Realpennies.com.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||